Asbestos in Craft Sand Forces More Than 450 Schools to Close Across Australia and New Zealand
Tremolite asbestos found in children's colored sand from China prompts school shutdowns, product recalls, and cleanup operations.
News & Research
149 articles
Latest mesothelioma updates and data-driven research from peer-reviewed sources
Latest News
news Judge Awards $24.6 Million After Gold Bond Talc Company Fails to Defend Mesothelioma Lawsuit
news Pelvic Mesothelioma Tumor Shrinks 83% With Immunotherapy in Rare Case Report
news Durvalumab Plus Chemotherapy Doubles Median Survival to 20 Months in Mesothelioma Trial
news UK Trial Tests Proton Beam Therapy for Mesothelioma, Targeting 50% Two-Year Survival
news Baltimore Jury Awards Record $1.56 Billion in Johnson and Johnson Talc Mesothelioma Case
news UK Recalls 14 Children's Sand Toys Over Asbestos Contamination
news Asbestos in Drinking Water Hits Five Times the Federal Limit in Brockway, Pennsylvania
news University of Hawaii Identifies L-BAM, a Treatable Form of Mesothelioma
research Where Is Mesothelioma Most Common? 2026 State-by-State Rankings
research Insulation Workers Face 46x the Risk: Mesothelioma by Occupation
research One in Three Mesothelioma Cases Is a Veteran: Risk by Military Branch
research CheckMate-743 at Five Years: 14% of People on Immunotherapy Still Alive
legal Banjima Traditional Owners Launch $1.5 Billion Asbestos Claim Over Wittenoom
exposure UK Recalls 14 Children's Toys Over Asbestos Contamination in Sand Products
legal 42 Talc Claimants Challenge Revlon's Bankruptcy Discharge in Second Circuit Appeal
legal California Appeals Court Rejects San Diego City Workers' Asbestos Lawsuit
exposure DHS Workers Report Asbestos Exposure at St. Elizabeths Demolition Site
exposure Washington Asbestos Contractor Fined $200K for Lying to Inspectors, Exposing Workers
legal Vanderbilt Minerals Files Chapter 11 Bankruptcy Over 1,400 Talc Lawsuits
treatment DREAM3R Phase 3 Trial: Durvalumab Plus Chemo Shows Signals but Falls Short of Proof
legal Smith Law Firm Sues Litigation Funders, Alleges "Loan-to-Own" Scheme in Talc Cases
legal Philadelphia Jury Finds J&J Liable in Talc Cancer Case, Awards $250K
research Baylor-Duke Trial Tests Immunotherapy Plus Chemo Before Mesothelioma Surgery
legal BNSF Railway Appeals $8M Libby, Montana Asbestos Verdict
research Blood Test Predicts Immunotherapy Response in Operable Mesothelioma
legal $51M Avon Talc Verdict Upheld in Mesothelioma Case
legal $34.2M Verdict Against John Crane in Oregon Shipyard Case
research Mount Sinai P/D Surgery Achieves Zero Mortality in Mesothelioma Study
research UCSF Proposes First Staging System for Peritoneal Mesothelioma
legal $18M Verdict in Florida Brake Dust Mesothelioma Lawsuit
legal Beasley Allen Disqualified From NJ Talc Litigation Over Ethics Violation
legal Asbestos Pipe Maker Sues Plaintiff Law Firm: What Patients Should Know
legal $8M Verdict: J&J Talc Mesothelioma Case in Massachusetts
research ADI-PEG20 Phase 3 Trial Shows Promise: ATOMIC-Meso Results
research TEAD Inhibitor IK-930 Shows Activity in Mesothelioma: ESMO Update
research UV1 Cancer Vaccine Receives FDA Fast Track for Mesothelioma
legal Judge Dismisses Fraud Lawsuit Against J&J Over Texas Two-Step Bankruptcy Strategy
clinical-trials Atezolizumab Phase 3 Trial for Pleural Mesothelioma
clinical-trials Atezolizumab Trial: Phase 1 Study for Mesothelioma
clinical-trials Atezolizumab Phase 1 Trial for Pleural Mesothelioma
clinical-trials CAR-T Trial NCT04981119 (A2 Biotherapeutics): Screening Study for Mesothelioma
clinical-trials CAR-T Trial NCT06051695 (A2 Biotherapeutics): Phase 1/2 Study for Mesothelioma
clinical-trials CAR-T Trial NCT06256055 (UTC Therapeutics): Phase 1 Study for Mesothelioma
clinical-trials CAR-T Trial NCT06885697 (NCI): Phase 1 Study for Mesothelioma
clinical-trials CAR-T Trial: Phase 1 Study for Pleural Mesothelioma
clinical-trials Immunotherapy Trial: Phase 1 Study for Mesothelioma
clinical-trials HIPEC Trial NCT05001880 (NCI): Phase 2 Study for Peritoneal Mesothelioma
clinical-trials HIPEC Trial NCT04847063 (NCI): Phase 1 Study for Peritoneal Mesothelioma
clinical-trials HIPEC Trial NCT06057935 (Memorial Sloan Kettering): Phase 2 Study for Peritoneal Mesothelioma
clinical-trials Immunotherapy Trial NCT03935893 (Udai Kammula): Phase 2 Study for Mesothelioma
clinical-trials Immunotherapy Trial NCT05730816 (Brigham & Women's): Phase 2 Study for Mesothelioma
clinical-trials Immunotherapy Trial NCT06477419 (MSK): Phase 2 Study for Mesothelioma
clinical-trials Immunotherapy Trial NCT06503146 (NCI): Phase 2 Study for Mesothelioma
news 92 Mesothelioma Clinical Trials Recruiting Now: What's Being Tested in 2026
clinical-trials Nivolumab + Ipilimumab Phase 1/2 Trial (NCT04665206)
clinical-trials Nivolumab + Ipilimumab Phase 2 Trial for Mesothelioma
clinical-trials Nivolumab + Ipilimumab Phase 1/2 Trial (NCT06362369)
clinical-trials Nivolumab + Ipilimumab Trial: Study for Mesothelioma
clinical-trials Nivolumab + Ipilimumab Phase 3 Trial (NCT06097728)
clinical-trials Nivolumab + Ipilimumab Phase 1/2 Trial (NCT07121374)
clinical-trials Nivolumab + Ipilimumab Phase 2 Trial (NCT04400539)
clinical-trials Pembrolizumab Trial NCT04897022 (Memorial Sloan Kettering): Phase 1 Study for Mesothelioma
clinical-trials Pembrolizumab Trial NCT05086692 (Medicenna): Phase 1/2 Study for Mesothelioma
clinical-trials Pembrolizumab Trial NCT03556228 (VM Oncology): Phase 1/2 Study for Mesothelioma
clinical-trials Pembrolizumab Trial NCT05579366 (Genmab): Phase 1/2 Study for Mesothelioma
clinical-trials Pembrolizumab Trial NCT05732831 (Tango Therapeutics): Phase 1/2 Study for Mesothelioma
clinical-trials Pembrolizumab Trial NCT06444815 (KaliVir): Phase 1 Study for Mesothelioma
clinical-trials Pembrolizumab Phase 2 Trial for Pleural Mesothelioma
research Hopkins Trial: Immunotherapy Before and After Surgery Extends Mesothelioma Survival
legal $20M Verdict Against J&J in Florida Mesothelioma Case
news The Asbestos Cover-Up: What the Industry Knew in 1930
exposure Your Mechanic May Be Breathing Asbestos Right Now
news 3,000 Americans Die From Mesothelioma Yearly
exposure The Hidden Danger in Your Ceiling
exposure Advocates Sue for East Wing Asbestos Records
research New Review Maps BAP1 Loss in Mesothelioma
exposure UK Recalls Children's Play Sand After Asbestos Found
news UK, EU Split on Talc Cancer Classification
legal $42.6M Verdict Against J&J in Massachusetts Mesothelioma Case
exposure Montana Windstorm Scatters School Asbestos
BREAKING Cell Therapy Shrinks Tumors in 63%
exposure Cassiar: The Town That Asbestos Built
legal Vi-Jon Talc Mesothelioma Case Settles in California
exposure Cold Lake School Closes After Asbestos Found
asbestos Malaysia Asbestos Ban Push Intensifies
legal $25M Verdict Against J&J in Connecticut Mesothelioma Case
legal U.S. Chamber Urges 5th Circuit to Vacate EPA Asbestos Ban
research MVdeltaC Measles Vaccine Gets FDA Orphan Drug Status for Mesothelioma
legal Virginia Supreme Court: Shipyards Owe Duty to Workers' Family Members
legal J&J Talc Verdicts Top $2.5B in 2025
news Mesothelioma Treatment Advances: 2025
BREAKING Record $1.56B Verdict Against J&J in Talc
legal $65.5M Verdict Against J&J in Minnesota Mesothelioma Case
legal $40M Verdict Against J&J in California Ovarian Cancer Case
research Drug Combo Achieves 60% Response Rate
news FDA Withdraws Talc Asbestos Testing Rule
treatment One Drug Halted, Another Advances
exposure Asbestos in Children's Art Sand: Australia
research Cyncado Therapeutics and ADDRI to Test TT-4 in Australian Mesothelioma Trial
legal Judge Allows Experts in 67,500 Talc Cases
exposure Japan Banned Asbestos in 2006, Cases Rise
exposure Minot AFB Missile Crews Face Asbestos Risk
research Mesothelioma Survival: 18-Year Survivor's Story
BREAKING $966M Verdict: Jury Finds J&J Concealed Talc Asbestos Risk
legal $966M Verdict Against J&J in California Mesothelioma Case
news Mesothelioma Awareness Day: September 26
research Mesothelioma Treatment: Hopkins Immunotherapy Trial
treatment VT3989 Doubles Time Without Progression
treatment Hopkins: Pre-Surgery Immunotherapy Success
treatment Trial Tests Immunotherapy Before Surgery
research IMPALA Trial: Light Therapy for Mesothelioma
legal New York Appeals Court Upholds $3.3 Million Ford Asbestos Brake Verdict
exposure Paramount Studios Faces Asbestos Suits
legal $117 Million Verdict Sets New York Record for Single-Plaintiff Asbestos Case
news Asbestos Disclosure Bill H.R.4247
exposure Libby, Montana: America's Deadliest Town
treatment Dual-Target Immunotherapy Shows 52% Response
news UK Commits £1.2B for Asbestos Removal
exposure UK Has World's Highest Meso Rates
exposure Canada Banned Asbestos, Cases Still Rise
treatment FDA Approves Opdivo Qvantig for Mesothelioma
exposure Utah Windstorm Spreads Mine Asbestos
treatment KEYNOTE-483: Keytruda Combo Approved
news 9/11 Mesothelioma Crisis Still Unfolding
research DENIM Trial: Vaccine Did Not Extend Survival
exposure WHO Classifies Talc as Probable Carcinogen
research MARS 2: Chemo Outperformed Surgery
exposure EPA Bans Chrysotile: First U.S. Asbestos Ban
treatment ATOMIC-Meso: Quadrupled 3-Year Survival
treatment CONFIRM Trial: Nivolumab Extends Survival
news 2023 Mesothelioma Verdicts: $40M+ Awards
news Court Rejects J&J's 2nd Talc Bankruptcy
treatment SynKIR-110 CAR-T Gets FDA Fast-Track
exposure J&J Discontinues Talc Baby Powder
news EPA Proposes Chrysotile Asbestos Ban
news J&J Creates LTL to Shield Talc Liability
legal J&J's Texas Two-Step: 3 Failed Attempts
news FDA OKs Opdivo+Yervoy for Mesothelioma
treatment CheckMate-743: Immunotherapy Beats Chemo
legal $750M Verdict Against J&J in New Jersey Mesothelioma Cases
legal Trial Attorney Chris Placitella on 40 Years Fighting Asbestos Companies
exposure FDA Finds Asbestos in J&J Baby Powder
news FDA Approves Optune Lua for Mesothelioma
exposure FDA Finds Asbestos in Claire's Makeup
legal $4.69B Verdict Against J&J in St. Louis Talc Case
exposure Brazil Bans Asbestos in Landmark 2017 Ruling
exposure Lautenberg Act: Path to Asbestos Ban
news Zadroga Act: Permanent Care for 9/11 Responders
Featured Coverage
In-depth reporting, data analysis, and investigations
DATA
Mesothelioma in Women: Survival Rates
Women with mesothelioma have 3x better 5-year survival than men. 91% of female cases are from secondary household asbestos exposure.